|
1
|
Zhu L, Yan W, Rodriguez-Canales J, et al:
MicroRNA analysis of microdissected normal squamous esophageal
epithelium and tumor cells. Am J Cancer Res. 1:574–584. 2011.
|
|
2
|
Motoyama K, Inoue H, Mimori K, et al:
Clinicopathological and prognostic significance of PDCD4 and
microRNA-21 in human gastric cancer. Int J Oncol. 36:1089–1095.
2010.
|
|
3
|
Chang KH, Miller N, Kheirelseid EA, et al:
MicroRNA-21 and PDCD4 expression in colorectal cancer. Eur J Surg
Oncol. 37:597–603. 2011.
|
|
4
|
Ribas J and Lupold SE: The transcriptional
regulation of miR-21, its multiple transcripts, and their
implication in prostate cancer. Cell Cycle. 9:923–929. 2010.
|
|
5
|
Giovannetti E, Funel N, Peters GJ, et al:
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome
and pharmacologic aspects underlying its role in the modulation of
gemcitabine activity. Cancer Res. 70:4528–4538. 2010.
|
|
6
|
Wei J, Gao W, Zhu CJ, et al:
Identification of plasma microRNA-21 as a biomarker for early
detection and chemosensitivity of non-small cell lung cancer. Chin
J Cancer. 30:407–414. 2011.
|
|
7
|
Tran N, Mclean T, Zhang X, et al: MicroRNA
expression profiles in head and neck cancer cell lines. Biochem
Biophys Res Commun. 358:12–17. 2007.
|
|
8
|
LeBiot PE, Burg G, Weedon D and Sarasin A:
World Health Organization Classification of Tumours. Pathology and
Genetics of Skin Tumours. IARC Press; Lyon: 2006
|
|
9
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
|
|
10
|
Jansen AP, Camalier CE and Colburn NH:
Epidermal expression of the translation inhibitor programmed cell
death 4 suppresses tumorigenesis. Cancer Res. 65:6034–6041.
2005.
|
|
11
|
Horiuchi A, Linuma H, Akahane T, et al:
Prognostic significance of PDCD4 expression and association with
microRNA-21 in each Dukes’ stage of colorectal cancer patients.
Oncol Rep. 27:1384–1392. 2012.
|
|
12
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005.
|
|
13
|
Wen YG, Wang Q, Zhou CZ, et al: Mutation
analysis of tumor suppressor gene PTEN in patients with gastric
carcinomas and its impact on PI3K/AKT pathway. Oncol Rep. 24:89–95.
2010.
|
|
14
|
Meng F, Henson R, Wehbe-Janek H, et al:
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene
in human hepatocellular cancer. Gastroenterology. 133:647–658.
2007.
|
|
15
|
Ming M and He YY: PTEN: new insights into
its regulation and function in skin. J Invest Dermatol.
129:2109–2112. 2009.
|
|
16
|
Zhang BG, Li JF, Yu BQ, et al: MicroRNA-21
promotes tumor proliferation and invasion in gastric cancer by
targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
|
|
17
|
Reis PP, Tomenson M, Cerciqne NK, et al:
Programmed cell death 4 loss increased tumor cell invasion and is
regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer.
9:2382010.
|
|
18
|
Ren J, Zhu D, Liu M, et al: Downregulation
of miR-21 modulates Ras expression to promote apoptosis and
suppression invasion of laryngeal squamous cell carcinoma. Eur J
Cancer. 46:3409–3416. 2010.
|
|
19
|
Yao Q, Xu H, Zhang QQ, et al: MicroRNA-21
promotes cell proliferation and down-regulates the expression of
programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Biochem Biophys Res Commun. 388:539–542. 2009.
|
|
20
|
Wang ZX, Lu BB, Wang H, et al: MicroRNA-21
modulates chemosensitivity of breast cancer cells to doxorubicin by
targeting PTEN. Arch Med Res. 42:281–290. 2011.
|
|
21
|
Liu M, Wu H, Liu T, et al: Regulation of
the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Cell Res. 19:828–837. 2009.
|
